Real world use of targeted therapies in war veterans with kidney cancer
A retrospective study of the use of targeted therapies for [...]
ESMO 2019: IKCC global patient survey of kidney cancer patients in 43 countries
Results from the International Kidney Cancer Coalition (IKCC) global patient [...]
Kidney cancer clinical trials: What you need to know
In this article, Deb Maskens, founder of Kidney Cancer Canada [...]
Promising early studies with pegilodecakin plus immunotherapy in pretreated kidney cancer
A recent phase 1b clinical trial investigated the use of [...]
Phase Ib cabozantinib plus atezolizumab combination study now open to kidney cancer patients in the UK
Based on promising efficacy findings, the COSMIC-021 clinical trial has [...]
NICE exploring ways to use real world data
The National Institute of Health and Care Excellence (NICE) is [...]
The role of biomarkers in predicting response to treatment in metastatic kidney cancer
This review published in Clinical Genitourinary Cancer summarises the current [...]
Patient engagement in clinical development
The National Institute for Health Research (NIHR) is rolling out [...]
Barriers to cancer clinical trial enrolment
This review presents the findings of a meta-analysis of 13 [...]
Real world evidence as a complement to clinical trials
The review article highlights the usefulness of real world evidence [...]
